临床试验/ISRCTN56551999

ISRCTN56551999已完成未知

Home versus Office blood pressure MEasurements: Reduction of Unnecessary treatment Study

The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)0 个研究点目标入组 430 人开始时间: 2006年12月6日最近更新: 2022年11月7日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 430

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

2003 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/14763665 2005 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/16257877 2006 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/16877956 2007 Results article in http://www.ncbi.nlm.nih.gov/pubmed/18047914 2007 Results article in http://www.ncbi.nlm.nih.gov/pubmed/17938383

研究设计

研究类型: Interventional

入排标准

性别: All

入选标准

•1. Males and females aged 18 years and above
•2. Average blood pressure between 139 and 200 mmHg for systolic or between 90 and 120 mmHg for diastolic blood pressure
•3. Participating subjects are physically and mentally able to measure their own blood pressure
•4. Subjects are willing to remain in follow-up during a period of one year
•5. Signed informed consent

排除标准

•1. The presence of clinically manifest cardiovascular events (angina pectoris, heart failure, hypertensive encephalopathy, or prior myocardial infarction or cerebrovascular accident)
•2. Severe non-cardiovascular disease (e.g. malignancy), which will interfere with adequate follow up
•3. Allergy or contra-indications for the antihypertensive drugs used in this study
•4. Serum creatinine above 150 micromol/l
•5. Clinically significant orthostatic hypotension (a drop in systolic blood pressure of more than 20 mmHg upon standing)
•6. Blood pressure devices

研究者

发起方

The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)

相似试验

进行中（未招募）

The Effect of Home Blood Pressure Measurement on the Management of HypertensionBlood PressureHome Blood Pressure MeasurementAmbulatory Blood PressureHypertension

NCT03868384DongGuk University701

A Cohort Study of Morning Home Blood Pressure Measurement in Type 2 Diabetic PatientsHypertensionType 2 Diabetes

NCT00760110Nagaoka Red Cross Hospital400

Long-term of 10 Years Results of a Prospective Longitudinal StudyBlood PressureType 2 Diabetes Mellitus

NCT01557972Nagaoka Red Cross Hospital400

The Japan Home vs. Office blood pressure Measurement Evaluation with AI <J-HOME AI> Multi-center randomized controlled study on efficacy of PREMINENT (losartan 50 mg/HCTZ 12.5 mg) and high-dose Angiotensin Receptor Blockers (ARBs) on home blood pressure / clinic blood pressure / augmentation index / central blood pressure in patients with uncontrolled hypertension under moderate-dose ARB monotherapyHypertension

JPRN-UMIN000000964J-HOME AI Study group200

The Japan Home vs. Office blood pressure Measurement Evaluation with CAndesartan and Restricted dose of Diuretic <J-HOME-CARD>Hypertension

JPRN-UMIN000003356J-HOME-CARD Study group200